Overview
Nicole Lanatra is a Hematologist Oncology provider in Mount Kisco, New York. Dr. Lanatra is rated as an Experienced provider by MediFind in the treatment of Acute Myeloblastic Leukemia with Maturation. Her top areas of expertise are Childhood Iron Deficiency Anemia, Iron Deficiency Anemia, Factor 11 Deficiency, and Factor V Leiden Thrombophilia.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- PPO
- INSURANCE PLAN
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
90 S Bedford Rd, Mount Kisco, NY 10549
Weill Medical College Of Cornell
Gail Roboz is a Hematologist Oncology specialist and an Oncologist in New York, New York. Dr. Roboz is rated as an Elite provider by MediFind in the treatment of Acute Myeloblastic Leukemia with Maturation. Her top areas of expertise are Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Leukemia, Bone Marrow Aspiration, and Bone Marrow Transplant.
Westchester Medical Center Advanced Physician Services PC
Karen Seiter is a Hematologist Oncology specialist and a Hematologist in Valhalla, New York. Dr. Seiter is rated as a Distinguished provider by MediFind in the treatment of Acute Myeloblastic Leukemia with Maturation. Her top areas of expertise are Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Leukemia, Bone Marrow Aspiration, and Bone Marrow Transplant.
Yale University
Amer Zeidan is a Hematologist Oncology specialist and an Oncologist in New Haven, Connecticut. Dr. Zeidan is rated as an Elite provider by MediFind in the treatment of Acute Myeloblastic Leukemia with Maturation. His top areas of expertise are Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Leukemia, Bone Marrow Transplant, and Bone Marrow Aspiration.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Childhood Iron Deficiency AnemiaDr. Lanatra isDistinguished. Learn about Childhood Iron Deficiency Anemia.
- Iron Deficiency AnemiaDr. Lanatra isDistinguished. Learn about Iron Deficiency Anemia.
- Advanced
- Acute Mountain SicknessDr. Lanatra isAdvanced. Learn about Acute Mountain Sickness.
- AgranulocytosisDr. Lanatra isAdvanced. Learn about Agranulocytosis.
- Alpha ThalassemiaDr. Lanatra isAdvanced. Learn about Alpha Thalassemia.
- Alpha Thalassemia X-Linked Intellectual Disability Syndrome
- AnemiaDr. Lanatra isAdvanced. Learn about Anemia.
- Chronic Familial NeutropeniaDr. Lanatra isAdvanced. Learn about Chronic Familial Neutropenia.
- Experienced
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Lanatra isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Acute Promyelocytic LeukemiaDr. Lanatra isExperienced. Learn about Acute Promyelocytic Leukemia.
- Adult Soft Tissue SarcomaDr. Lanatra isExperienced. Learn about Adult Soft Tissue Sarcoma.
- ALK-Positive Non-Small Cell Lung CancerDr. Lanatra isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.